Multidimensional therapeutic advantages of Smilax glabra (Tufuling)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction

• by Qiaoyun Liu, Xiuming Li, Yuping Lin, Xianyu Tang, Guanjie Fan, Lu Sun

• July 1, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients

• by Andrea Surnit

• May 11, 2026

• 4 min

Evaluating the Quality and Content of Videos on Gout Available on Online Platforms: A Cross-Sectional Analysis

• by Xiangsheng Ye, Hao Sun, Wenze Jiang, Yuqing Zhu

• February 1, 2026